RV7 fundamentals
HALOZYME THERAPEUT earnings per share and revenue
RV7 earnings per share for the last quarter are 0.98 CHF whereas the estimation was 0.82 CHF which accounts for 20.18% surprise. Company revenue for the same period amounts to 234.47 M CHF despite the estimated figure of 203.70 M CHF. Estimated earnings per share for the next quarter are 0.98 CHF, and revenue is expected to reach 226.92 M CHF. Also watch annual changes over time to get a bigger picture of RV7 earnings per share and revenue dynamics.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise